A new treatment for atopic dermatitis may offer relief from dogs with allergies. The treatment, Cytopoint, is an injectable monoclonal antibody therapy approved to treat atopic dermatitis — symptoms of which include itching skin — in dogs. Treatments are typically administered every one to two months.
“As the owner of allergic pets, I understand the frustration that my clients feel, and as a person with allergies myself, I understand what my patients feel. With Cytopoint, in a single injection, we now have an excellent opportunity to help control the itch without leading to any secondary signs that can be more difficult to manage than the itch itself.”
— Laura Stokking, PhD, DVM, DACVD, Veterinary Specialty Hospital
Following its licensing for use by the USDA, Cytopoint has been made available to veterinarians in the United States through it developer, Zoetis. Cytopoint joins Apoquel, another Zoetis product, among the company’s new treatments for canine itch.